| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 177.52B | 175.29B | 167.00B | 152.68B | 144.44B | 135.48B |
| Gross Profit | 19.11B | 19.59B | 17.99B | 14.15B | 15.14B | 13.44B |
| EBITDA | 7.72B | 8.04B | 7.52B | 7.94B | 7.61B | 6.21B |
| Net Income | 5.04B | 5.18B | 4.69B | 4.67B | 4.20B | 3.75B |
Balance Sheet | ||||||
| Total Assets | 105.23B | 118.18B | 115.24B | 101.25B | 93.03B | 90.13B |
| Cash, Cash Equivalents and Short-Term Investments | 13.85B | 23.89B | 16.83B | 13.03B | 11.89B | 13.19B |
| Total Debt | 17.18B | 14.22B | 21.56B | 14.98B | 10.33B | 10.68B |
| Total Liabilities | 60.61B | 67.97B | 69.10B | 52.54B | 48.37B | 47.46B |
| Stockholders Equity | 44.23B | 49.76B | 45.71B | 47.62B | 44.00B | 42.20B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 18.08B | 4.97B | -3.60B | 1.20B | 366.00M |
| Operating Cash Flow | 0.00 | 18.41B | 5.18B | -3.17B | 1.35B | 1.56B |
| Investing Cash Flow | 0.00 | -799.00M | -784.00M | 2.65B | 934.00M | -2.26B |
| Financing Cash Flow | 0.00 | -11.02B | -913.00M | 1.41B | -3.66B | -2.27B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥97.14B | 6.30 | ― | 4.38% | -6.07% | 44.83% | |
74 Outperform | ¥83.03B | 16.30 | ― | 0.99% | 21.37% | 44.91% | |
73 Outperform | ¥77.96B | 12.54 | ― | 1.25% | 4.37% | 6.30% | |
68 Neutral | ¥78.00B | 23.02 | ― | 8.02% | -4.15% | -16.83% | |
65 Neutral | ¥83.47B | 24.41 | ― | 0.96% | 0.26% | 5.89% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | ¥68.99B | 15.25 | ― | 3.64% | 4.96% | 17.55% |